Basal Cell Carcinoma of the Head and Neck
Author(s) -
Masahiro Nakayama,
Keiji Tabuchi,
Yasuhiro Nakamura,
Akira Hara
Publication year - 2010
Publication title -
journal of skin cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.309
H-Index - 10
eISSN - 2090-2905
pISSN - 2090-2913
DOI - 10.1155/2011/496910
Subject(s) - basal cell carcinoma , medicine , head and neck , skin cancer , radiation therapy , lesion , basal cell , head and neck cancer , basal (medicine) , epidermis (zoology) , dermatology , head and neck squamous cell carcinoma , carcinoma , cancer , pathology , radiology , surgery , anatomy , insulin
Basal cell carcinoma (BCC) is a malignant neoplasm derived from nonkeratinizing cells that originate from the basal layer of the epidermis and is the most frequent type of skin cancer in humans, with cumulative exposure to ultraviolet radiation as an important risk factor. BCC occurs most frequently at sun-exposed sites, with the head and neck being common areas. Tumors can be classified as nodular, superficial, morpheaform, infiltrating, metatypic, and fibroepithelioma of Pinkus. Several treatment options such as surgical excision and nonsurgical procedures are available. The choice of treatment should be determined based on the histological subtype of a lesion, cost, its size and location, patient age, medical condition of the patient, treatment availability, and the patient's wishes. The aim of any therapy selected for BCC treatment involving the head and neck is to ensure complete removal, the preservation of function, and a good cosmetic outcome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom